Core Viewpoint - Shanghai Kaikai Industrial Co., Ltd. plans to transfer 11.11% equity stake in Nanjing Tianshi Software Technology Co., Ltd. to enhance asset utilization efficiency and focus on core business development [9][12][20] Group 1: Equity Transfer - The company intends to publicly transfer its 11.11% stake in Nanjing Tianshi through the Shanghai United Assets and Equity Exchange, with a minimum transfer price of 1,741.23 million RMB based on a pre-evaluation value of 15,672.62 million RMB as of December 31, 2024 [9][19][20] - The decision to transfer the stake was approved unanimously by the board of directors, with 9 votes in favor and no opposition [3][14] - The transaction does not constitute a related party transaction or a major asset restructuring, and it does not require shareholder approval [10][11][12] Group 2: Internal Loan Authorization - The company authorized an increase in the internal loan limit to its wholly-owned subsidiaries from 12 million RMB to 25 million RMB to support the transformation of its "big health" business strategy [4][5] - The internal loans will have an interest rate not lower than the prevailing loan market quotation rate (LPR) and can be reused [4][5] - This internal loan authorization aims to facilitate the rapid development of the subsidiaries' business without adversely affecting the company's financial health [4][5] Group 3: Company Strategy and Future Outlook - The equity transfer aligns with the company's strategic focus on enhancing investment efficiency and reducing investment risks, thereby optimizing its investment structure [13][20] - Post-transaction, the company will no longer hold any equity in Nanjing Tianshi, allowing it to concentrate resources on its core competencies and the "big health" industry transformation [13][20] - The company emphasizes that the transaction will not negatively impact its future financial status or operational results [21]

Core Points - The company is focusing on divesting low-efficiency assets to enhance resource allocation and improve asset utilization efficiency by transferring 11.11% equity in Nanjing Tianshi Software Technology Co., Ltd. [1] - The board approved an increase in the internal loan limit to support the full subsidiary's transformation in the "big health" industry, raising the total limit to 25 million RMB [2][3] Group 1 - The board meeting was held on August 1, 2025, with all 9 directors present, and the meeting complied with relevant laws and regulations [1] - The decision to transfer equity was made to focus on core business development and improve asset utilization [1] - The internal loan authorization aims to support the subsidiary's funding needs during its transformation in the "big health" sector [2][3] Group 2 - The internal loan will be sourced from the company's own funds and is not expected to negatively impact the company's ongoing operations or financial status [3] - The internal loan interest rate will not be lower than the prevailing loan market quotation rate [2]

Core Viewpoint - The company plans to transfer its 11.11% stake in Nanjing Tianshi Software Technology Co., Ltd. through a public listing on the Shanghai United Assets and Equity Exchange, with a pre-evaluation price of 157 million yuan [1] Group 1: Transaction Details - The minimum transfer price for the stake will not be less than 17.41 million yuan, which corresponds to the pre-evaluation value of the 11.11% stake [1] - After the transaction, the company will no longer hold any equity in Nanjing Tianshi [1] Group 2: Strategic Focus - This transaction is part of the company's strategy to concentrate resources on its core strengths and to implement a significant transformation towards the "big health" industry [1]

股票代码：600272 股票简称：开开实业 编号：2025-008 900943 开开 B 股 上海开开实业股份有限公司 关于公司 2024 年度向特定对象发行 A 股股票 涉及关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 上海开开实业股份有限公司（以下简称："公司"）拟向上海开 开（集团）有限公司（以下简称："开开集团"）发行A股股票，拟募 集资金总额不超过159,770,312.85元（含本数），发行数量19,651,945股。 开开集团拟以现金方式认购本次发行的股份。 公司本次向特定对象发行A股股票（以下简称"本次发行"）对 象为公司控股股东开开集团，系公司关联方，根据《上海证券交易所 股票上市规则》的规定，开开集团认购公司股票构成关联交易。 本次发行不构成《上市公司重大资产重组管理办法》规定的重 大资产重组。 本次发行相关事宜尚需经上海证券交易所（以下简称："上交 所"）审核通过并获得中国证券监督管理委员（以下简称"中国证监会"） 会作出同意注册的决定后方可实施。上述事项的审核通过 ...